SLC22A16 and obesity disorder: As such, some of the genome-wide associations reported here (e.g., carnitine and SLC22A16) may be translationally relevant beyond transfusion medicine when interpreted in the context of markers relevant to specific diseases (e.g., carnitine metabolism and obesity (27)).